Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.98 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.